| miR-374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer. | gastric, |
| miR-374a functions as an oncogene in osteosarcoma, and the miR-374a/Axin2 axis might represent a potential therapeutic target for OS intervention. | osteosarcoma, |
| these findings suggest that miR-374a functions as a candidate oncogene in GC by directly targeting SRCIN1 | None |